Trial · NCT07886034
Sphenopalatine Ganglion Block Combined With Either Scalp Nerve Block or Local Wound Infiltration for Postoperative Analgesia in Adult Patients Undergoing Craniotomy: A Randomized Controlled Trial
NCT07886034, Not applicable, Not yet recruiting, Zagazig University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Sphenopalatine Ganglion Block Combined With Either Scalp Nerve Block or Local Wound Infiltration for Postoperative Analgesia in Adult Patients Undergoing Craniotomy: A Randomized Controlled Trial. Trials, record NCT07886034. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07886034
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sphenopalatine Ganglion Block Combined With Either Scalp Nerve Block or Local Wound Infiltration for Postoperative Analgesia in Adult Patients Undergoing Craniotomy: A Randomized Controlled Trial
- NCT number
- NCT07886034
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 54 participants, estimated
- Lead sponsor
- Zagazig University
- Conditions
- Craniotomy Surgery
- Interventions
Group (c): control group patients will receive general anesthesia., Group (SS): Sphenopalatine Ganglion Block with either Scalp Nerve Block, Group (SL): patients will receive Sphenopalatine Ganglion Block with local wound infiltration
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The time interval from patient recovery to the first use of rescue analgesia (nalbuphine) | the first time after recovery from anesthesia when visual analog scale more than or equal 3 at first 24 hours postoperative | the time interval between recovery from anesthesia and the need for rescue analgesia |
| Secondary | post-craniotomy pain | at 0 minutes and 1,2,4,6,8 ,12,18,24 hours postoperative. | 1-Measuring the Intensity of post-craniotomy pain during the first 24 hours after surgery using a validated pain scale as Visual Analog Scale, 0-10, which is a tool used to measure subjective experience of the patient, it consists of 10 cm ranging from zero which equal no pain till 10 which equal severe pain. |
| Secondary | Intraoperative patient (Blood Pressure by mmHg ) | will be recorded at baseline (once patient shifted to operating room) and every 5 minutes in the first 30 minute then every 15minutes until the end of surgery | Intraoperative vital sign of the patients (Blood Pressure by mmHg) will be recorded at baseline (once patient shifted to operating room) and every 5 minutes in the first 30 minute then every 15minutes until the end of surgery |
| Secondary | Total Dose of rescue analgesia (nalbuphine) mg | in the first 24 hours will be recorded. | Total Dose of rescue analgesia (nalbuphine) by mg used in the first 24 hours will be recorded. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07886034
GET https://conductscience.org/api/trials/v1/NCT07886034/registered